BILL ANALYSIS

HR9377

NEUTRAL

To establish a grant program for preparing and responding to New World screwworm outbreaks, and for other purposes.

HR9377 (To establish a grant program for preparing and responding to New World screwworm outbreaks, and for other purposes.) has been assessed with a neutral outlook for investors. The primary sectors impacted are Agriculture. View the full bill text on Congress.gov.

neutral

Market Sentiment

Affected Stocks

Sectors Impacted

Key Takeaways for Investors

HR9377 is in earliest legislative stage — referred to committee, no hearing or markup scheduled.

No authorized funding amount specified; actual spending requires a separate appropriations process.

No direct revenue impact on any publicly traded agriculture company identified in the current data.

How HR9377 Affects the Market

No market implications from HR9377 at this stage. The agriculture sector tickers listed in the financial data are not affected. The bill is a procedural step with no funding mechanism, no contract awards, and no regulatory mandate targeting any public company. Investors should monitor for committee action or a companion bill in the Senate before reassessing, but the current impact is zero.

Bill Details

Metric	Value
Bill Number	HR9377
Market Sentiment	neutral
Event Date	June 18, 2026
Affected Sectors	Agriculture
Affected Stocks	N/A
Source	View on Congress.gov →

Summary

HR9377 is a bill to establish a grant program for New World screwworm outbreak preparedness and response. It was referred to the House Agriculture Committee on June 18, 2026, an early procedural step. The bill does not specify an authorized funding amount, and actual appropriations would require separate legislation. The market impact on agriculture companies is negligible at this stage.

Full AI Market Analysis

On June 18, 2026, Rep. Vasquez (D-NM) introduced HR9377, a bill to create a grant program for preparing and responding to New World screwworm outbreaks. The bill was referred to the House Committee on Agriculture, its only committee assignment. With 13 cosponsors and a single referral, this is an early-stage, limited-scope authorization bill. No specific funding amount is stated in the bill text provided, meaning any eventual program would require a subsequent appropriations bill to allocate actual dollars. As an authorization bill that has not yet been marked up, voted on, or funded, it poses no near-term revenue impact on publicly traded agriculture companies. The agriculture sector tickers listed in the financial data — $DE, $CF, $CTVA, $BG, $ADM, $FMC, $MOS — are large-cap companies with annual revenues ranging from $4.5B to $61.3B. Even if a screwworm grant program were eventually funded, the amounts would be a tiny fraction of these companies' revenues, and no specific contractual mechanism ties this bill to any of them. No historical precedent data is available for similar biosecurity bills affecting these specific companies.